ARRECTOR

roflumilast · Arcutis Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARRECTOR, covering 2025-07-17 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR) [Phase 3]